Great Valley Advisor Group, Inc. Moderna, Inc. Transaction History

Great Valley Advisor Group, Inc.

$3.45 Billion
Q2 2024

A detailed history of Great Valley Advisor Group, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Great Valley Advisor Group, Inc. holds 7,343 shares of MRNA stock, worth $463,783. This represents 0.03% of its overall portfolio holdings.

Number of Shares

7,343

Previous 7,974 7.91%

Holding current value

$463,783

Previous $849,000 2.59%

% of portfolio

0.03%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	SELL	$101.21 - $166.61 $63,863 - $105,130	-631 Reduced 7.91%	7,343 $871,000
Q1 2024 May 03, 2024	BUY	$85.37 - $115.44 $15,622 - $21,125	183 Added 2.35%	7,974 $849,000
Q4 2023 Feb 05, 2024	SELL	$69.51 - $104.43 $34,963 - $52,528	-503 Reduced 6.06%	7,791 $774,000
Q3 2023 Nov 06, 2023	SELL	$96.41 - $126.61 $39,238 - $51,530	-407 Reduced 4.68%	8,294 $856,000
Q2 2023 Aug 10, 2023	SELL	$118.5 - $160.53 $27,136 - $36,761	-229 Reduced 2.56%	8,701 $1.06 Million
Q1 2023 May 02, 2023	BUY	$135.66 - $197.02 $501,670 - $728,579	3,698 Added 70.68%	8,930 $1.37 Million
Q4 2022 Jan 31, 2023	BUY	$118.38 - $210.04 $329,806 - $585,171	2,786 Added 113.9%	5,232 $939,000
Q3 2022 Oct 21, 2022	SELL	$118.07 - $194.18 $202,371 - $332,824	-1,714 Reduced 41.2%	2,446 $289,000
Q2 2022 Jul 19, 2022	BUY	$117.13 - $176.59 $157,891 - $238,043	1,348 Added 47.94%	4,160 $595,000
Q1 2022 Apr 20, 2022	BUY	$126.46 - $235.05 $12,519 - $23,269	99 Added 3.65%	2,812 $490,000
Q4 2021 Feb 10, 2022	SELL	$225.82 - $368.51 $1.81 Million - $2.95 Million	-7,998 Reduced 74.67%	2,713 $695,000
Q3 2021 Oct 14, 2021	BUY	$221.9 - $484.47 $1.05 Million - $2.29 Million	4,734 Added 79.2%	10,711 $4.12 Million
Q2 2021 Jul 27, 2021	SELL	$129.91 - $234.98 $52,353 - $94,696	-403 Reduced 6.32%	5,977 $1.4 Million
Q1 2021 Apr 20, 2021	SELL	$109.18 - $185.98 $223,709 - $381,073	-2,049 Reduced 24.31%	6,380 $835,000
Q4 2020 Jan 29, 2021	SELL	$65.74 - $169.86 $51,342 - $132,660	-781 Reduced 8.48%	8,429 $881,000
Q3 2020 Oct 21, 2020	SELL	$54.34 - $94.85 $137,045 - $239,211	-2,522 Reduced 21.5%	9,210 $651,000
Q2 2020 Jul 31, 2020	SELL	$29.67 - $80.0 $19,137 - $51,600	-645 Reduced 5.21%	11,732 $753,000
Q1 2020 May 15, 2020	BUY	$17.78 - $31.58 $220,063 - $390,865	12,377 New	12,377 $370,000

Others Institutions Holding MRNA

# of Institutions

1,114

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $24.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Valley Advisor Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Great Valley Advisor Group, Inc. with notifications on news.

Account

Great Valley Advisor Group, Inc. Moderna, Inc. Transaction History